Table 2.
Clinical data relating to population of cats in which the eGFR was developed and the population of cats in which the eGFR formula was tested. Continuous variables are presented as mean ± SD. FN ‐ female neutered, MN ‐ male neutered, DSH/DLH ‐ domestic short hair/domestic longhair
eGFR formula development population (n = 55) | eGFR formula testing population (n = 25) | P value | |
---|---|---|---|
Age (yrs) | 12.8 ± 3.2 | 12.4 ±3.7 | .626 |
Sex | FN n = 27 MN n = 28 |
FN n = 13 MN n = 12 |
.830 |
Breed | DSH/DLH n = 40 Pedigree n = 15 |
DSH/DLH n = 17 Pedigree n = 8 |
.885 |
GFR (mL/min/kg) | 1.54 ± 0.57 | 1.87 ± 0.56 | .016 |
Serum creatinine concentration (μmol/L) | 154.15 ± 50.55 | 155.89 ± 52.86 | .941 |
Reciprocal of serum creatinine concentration (μmol/L) | 0.007 ± 0.002 | 0.007 ± 0.002 | .925 |
Serum urea concentration (mmol/L) | 12.02 ± 3.80 | 12.28 ± 4.00 | .895 |
USG | 1.046 ± 0.022 | 1.039 ± 0.021 | .200 |
Body weight (kg) | 4.42 ± 1.14 | 4.20 ± 1.31 | .463 |
Body condition score (1‐9) | 6 ± 1 | 5 ± 1 | .228 |
Fat‐free mass (kg) | 3.07 ± 0.62 | Not measured | n/a |
Predicted fat‐free mass (kg) | 3.05 ± 0.59 | 3.02 ± 0.71 | .909 |
Predicted muscle mass (kg) | 2.02 ± 0.51 | 1.99 ± 0.66 | .824 |
Left forelimb circumference (cm) | 8.29 ± 0.94 | 7.91 ± 0.96 | .103 |
Right forelimb circumference (cm) | 8.05 ± 0.91 | 8.12 ± 0.89 | .621 |
Left hindlimb circumference (cm) | 9.22 ± 1.01 | 8.93 ± 1.12 | .242 |
Right hindlimb circumference (cm) | 9.03 ± 1.08 | 8.82 ± 0.95 | .416 |
Left proximal hindlimb circumference (cm) | 24.60 ± 4.04 | 23.30 ± 2.80 | .152 |
Right proximal hindlimb circumference (cm) | 25.95 ± 4.30 | 23.72 ± 3.36 | .026 |
Thoracic circumference (cm) | 40.34 ± 4.93 | 39.28 ± 4.84 | .378 |
Pelvic circumference (cm) | 41.00 ± 7.04 | 38.48 ± 6.73 | .141 |
Body length (cm) | 53.30 ± 5.14 | 53.28 ± 2.71 | .983 |
Forelimb height (cm) | 26.70 ± 3.13 | 36.93 ± 3.04 | .764 |
Hindlimb height (cm) | 29.61 ± 3.29 | 28.14 ± 3.04 | .062 |